Stent graft balloon catheters are soft catheters equipped with inflatable balloons, and are utilized during a catheterization process, in order to enlarge the narrow opening in coronary artery. Stent graft balloon catheter are generally used to expand vascular prosthesis, or at times of temporary occlusion of huge vessels, thereby utilized in several endovascular treatment of thoracic, aortic, and abdominal diseases.
Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=149
Usually, stent graft balloon catheters are adopted in balloon angioplasty and bypass graft surgery. These stents prevent risks related to re-narrowing that occurs in several patients undergoing angioplasty, as well as risks associated with abrupt artery closure. On the back of these benefits, demand for stent graft balloon catheters is on a rise. The market for stent graft balloon catheter has witnessed a gradual evolution from simple stents to the modified balloon stent catheters. Over the recent past, number of hospital admissions has witnessed a surge, owing to rising incidences of atherosclerosis, and growing prevalence of coronary artery disease (CAD) around the world. A number of technological developments have been observed in balloon catheters, coupled with the rise in healthcare expenditure.
However, angioplasty procedures are unaffordable, particularly for population thriving in underdeveloped and developing economies, which in turn might restrain demand for stent graft balloon catheters. Introduction of drug eluting balloons has highly favored growth of the market. Moreover, rising inclination toward adoption of balloons with drug delivery, capable of delivering medication at local sites, have proved to be effective alternatives to administer the drug intravenously. Several product developments in stent graft balloon catheters are being approved by regulatory bodies for treating vascular diseases. For example – the FDA has recently approved an expandable balloon stent graft developed by W.L. Gore & Associates for treatment of the peripheral artery disease. Sophisticated healthcare infrastructure, rising awareness about angioplasty procedures, and technological advancements in stent graft balloon catheters across developed economies are further expected to influence growth of the market in the upcoming years.
Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market
1) Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
2) Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
3) Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
4) Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
5) Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.
6) Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
7) Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
8) Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.
Browse Full Report with TOC @ https://www.factmr.com/report/149/stent-graft-balloon-catheter-market
Competition Tracking
Market players listed in Fact.MR’s report on the global market for stent graft balloon catheter include Medtronic Plc, Cordis Corporation, B. Braun Melsungen AG, Cook Medical INC, Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, Jotech GmbH, Cardionovum GmbH, Hexacath, Abbott Laboratories, and Meril Life Sciences Pvt. Ltd.
Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=149
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized “Healthcare Market Research Reports”. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/